Marianna Shelenkova

Marianna A. Shelenkova

Senior Associate

Marianna Shelenkova's practice focuses on corporate and financial transactions, particularly on public and private securities offerings, representing both issuers and underwriters in initial public offerings, follow-on offerings, private placements and sovereign debt offerings. She also regularly advises clients on a broad range of general corporate law, corporate governance and Securities and Exchange Commission compliance matters, including assisting public companies in the preparation of their periodic securities law filings.


  • Cyrus Capital Partners L.P., as a selling stockholder in connection with Virgin America Inc.'s initial public offering of $300,000,000 on the NASDAQ Global Select Market.
  • VimpelCom Holdings B.V., a multi-national telecommunications company, in its offering of $600,000,000 5.20% notes, $1,000,000,000 5.95% notes and RUB 12,000,000,000 9.00% notes in a Rule 144A/Regulation S private placement.
  • Memorial Resource Development Corporation, in its private issuance of $600,000,000 5.875% senior notes.
  • Representing a syndicate of underwriters in the issuance by the Republic of Turkey of $1,000,000,000 6.25% notes and in the issuance of $1,500,000,000 6.25% notes.
  • Multiple lead managers in the issuance by the Republic of Latvia of $1,000,000,000 5.25% notes.
  • Merck & Co. in the $8.5 billion financing associated with its $41 billion merger with Schering-Plough.



Latin Lawyer
"Private Equity Deal of the Year" (2019)


  • JD, Northwestern University School of Law, 2008
  • BA, University of Pennsylvania, 2001
  • New York

Email Disclaimer